Tech.euEurope
Human cell programming company bit.bio closes $25M Series D

Human cell programming company bit.bio has secured $25 million in Series D funding to expand its portfolio of human cell models and increase access to its technology for pharmaceutical companies…
Read at Tech.eu ↗Related

EuropeRiga-based Unitoq raises €155K in pre-seed to make real estate investment more accessible Tech.eu

EuropeCyberKord raises €2.7M to automate IT and cybersecurity operations with AI Tech.eu

EuropeEx-Phoenix Court partner launches $17M debut solo fund to discover next Lovable Tech.eu

EuropeQuint Computing raises €9.1M to scale quantum computing technology Tech.eu

EuropeTumbleweed raises record €6.9M seed round to bring microgravity research to the masses Tech.eu
